Related references
Note: Only part of the references are listed.Epidemiology of pyoderma gangrenosum in Japanese patients by questionnaire survey
Toshiyuki Yamamoto
JOURNAL OF DERMATOLOGY (2019)
Tumor necrosis factor-α inhibitors for the treatment of pyoderma gangrenosum not associated with inflammatory bowel diseases: A multicenter retrospective study
Laurie Rousset et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2019)
Pyoderma Gangrenosum: An Update on Pathophysiology, Diagnosis and Treatment
Afsaneh Alavi et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2017)
Successful Use of Adalimumab for Treating Pyoderma Gangrenosum with Ulcerative Colitis under Corticosteroid-tapering Conditions
Shintaro Sagami et al.
INTERNAL MEDICINE (2015)
Pathophysiology of pyoderma gangrenosum (PG): An updated review
Sara F. Braswell et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
Anthony D. Ormerod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial
Anthony D. Ormerod et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Pyoderma gangrenosum: challenges and solutions
Ana Gameiro et al.
CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY (2015)
Etiology and Management of Pyoderma Gangrenosum A Comprehensive Review
Iris Ahronowitz et al.
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2012)
Adalimumab: a Treatment Option for Pyoderma Gangrenosum After Failure of Systemic Standard Therapies
Louisa Hinterberger et al.
DERMATOLOGY AND THERAPY (2012)
Pyoderma gangrenosum: an updated review
E. Ruocco et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2009)
Successful use of adalimumab for treating fistulizing Crohn's disease with pyoderma gangrenosum: Two birds with one stone
Eva Zold et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Pyoderma gangrenosum - a review
Uwe Wollina
ORPHANET JOURNAL OF RARE DISEASES (2007)
Adalimumab treatment for pyoderma gangrenosum
Michael P. Heffernan et al.
ARCHIVES OF DERMATOLOGY (2007)
Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial
TN Brooklyn et al.
GUT (2006)
Systemic pyoderma gangrenosum responding to infliximab and adalimumab
VG Hubbard et al.
BRITISH JOURNAL OF DERMATOLOGY (2005)
Share Paper
